<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	>
<channel>
	<title>Comments on: Heptares Secures $30M in Series A Funding</title>
	<atom:link href="http://www.pharmababble.com/heptares-secures-gbp21-million-in-series-a-fund-raising-to-accelerate-development-of-pipeline-of-small-molecules-against-high-value-gpcr-drug-targets/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.pharmababble.com/heptares-secures-gbp21-million-in-series-a-fund-raising-to-accelerate-development-of-pipeline-of-small-molecules-against-high-value-gpcr-drug-targets/</link>
	<description>Biomedical investment and business development chatter</description>
	<pubDate>Fri, 12 Mar 2010 04:05:34 +0000</pubDate>
	<generator>http://wordpress.org/?v=2.7.1</generator>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	</channel>
</rss>
